Influenza A virus vaccine H1N1 - Adimmune Corporation

Drug Profile

Influenza A virus vaccine H1N1 - Adimmune Corporation

Alternative Names: Adimflu-S; Adimflu-S Children; Seasonal influenza virus vaccine - Adimmune

Latest Information Update: 18 May 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Adimmune Corporation
  • Class Influenza A virus H1N1 vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Influenza A virus H1N1 subtype

Most Recent Events

  • 11 May 2017 Launched for Influenza-A virus H1N1 subtype (Prevention) in China (IM) (SC)
  • 10 May 2017 Registered for Influenza-A virus H1N1 subtype (Prevention) in China (IM) (SC)
  • 31 Dec 2010 Launched for Influenza A virus H1N1 subtype (prevention) in Taiwan (SC)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top